Press Releases

Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035

CluePoints Appoints New Chief People Officer to Support Next Phase of Global Growth

CluePoints, provider of leading statistical and AI-driven software solutions, has appointed Sinead Godkin as its new Chief People Officer (CPO).

EEDEE Law Expands Clinical Research Support Services and Adds Industry Veteran Helen Montevago to Growing Team

Hovione’s people-first approach recognized as it achieves Top Employer certification for the fourth consecutive year

Hovione, an international integrated pharmaceutical development and manufacturing organization, has achieved Top Employer certification across all four of its manufacturing sites worldwide for the fourth consecutive year.

ELRIG Announces Drs Stephen Ward and Annarita Miccio as Keynote Speakers for Cell and Gene Therapy 2026

• Inaugural event takes place from 9–10 March at Hinxton Hall in Cambridge, UK • Programme spans neurological disorders, sensory diseases, rare conditions, and cancer immunotherapy

PHC Corporation of North America Launches TwinGuard® ECO 703VXH Freezer, Bringing New Energy Efficiency to Research Sample Protection

The PHCbi TwinGuard® ECO freezer ultra-low temperature (ULT) freezer is engineered to deliver enhanced energy efficiency and expanded operational monitoring for biorepositories, biopharmaceutical companies, and academic institutions.

Kindeva Announces Leadership Transition to Drive Strategic Growth

From Tokyo to Osaka: PSI Continues Japan Expansion with New Office in Osaka

Gifthealth Announces Jeremy Richardson as New Chief Commercial Officer

Gifthealth has announced the appointment of Jeremy Richardson as its new Chief Commercial Officer (CCO).

Astoriom Appoints Will Edwards as Chief Executive Officer

Strategic appointment to support global scale-up of sample management operations

Integrated DNA Technologies Expands Synthetic Biology Portfolio with Ansa Biotechnologies’ Clonal DNA and XL Clonal DNA Products

IDT and Ansa announced that Ansa’s Clonal DNA and XL Clonal DNA products, ranging from 100 bp to 50 kb, will be made available to IDT customers. This strategic collaboration enables more researchers to design and assemble longer, more complex constructs for next-generation cell and gene therapy discovery, vaccine research, and agrigenomics applications. The full press release is below.

Cellistic Launches Three New iPSC-based GMP Manufacturing Platforms to advance Immuno-Oncology and Regenerative Cell Therapies

Hongene Biotech Announces Grant to Expand Global Access to mRNA Vaccine Raw Materials

Cycle Pharmaceuticals and Inceptua Group Expand the Free Goods Programme for Patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU) to Include Morocco and Egypt

Cycle and Inceptua have announced the expansion of their partnership to make NITYR® tablets available via a Free Goods Programme for eligible patients with HT-1 and AKU to include Morocco and Egypt.

Veeva and BioMarin Form Long-Term Strategic Partnership

Codexis Expands Reach of the ECO Synthesis® Manufacturing Platform through a Signed Evaluation Agreement with Axolabs for Oligonucleotide Therapeutics 

LabConnect Establishes New Global Headquarters in Raleigh-Durham Area

LabConnect has established its new global headquarters in the Raleigh-Durham area to strategically align itself with the Research Triangle’s dense network of biotechnology and pharmaceutical partners. The new command center will house executive leadership and technology teams, overseeing an asset-light network of seven operational sites that support complex clinical trials across the globe. By moving to this hub, the company aims to accelerate innovation in drug development while aggressively scaling its local workforce in data science and scientific operations.

PharmaForceIQ Acquires Aktana to Deliver Unparalleled Cross-Functional Engagement Impact for Pharma

PharmaForceIQ has announced its acquisition of Aktana, aligning its cutting-edge digital orchestration platform with the industry’s premier AI-driven field Next-Best-Action (NBA) platform.

Biopharma PEG Expands Integrated PEGylated Protein Development Platform

Sanome announces two UK hospital partnerships to deploy AI-powered clinical intelligence for earlier infection detection